METHOD FOR ESTIMATING PSORIATIC ERYTHRODERMIA TREATMENT EFFECTIVENESS

摘要

FIELD: medicine.;SUBSTANCE: method involves determining acid alpha-1 glycoprotein and nitrogen oxide content at the time of disease exacerbation and at the moment the patient treatment being over. Acid alpha-1 glycoprotein content reduction being 1.5-1.6 times as high, and nitrogen oxide being 1.8-2.2 times as high, when compared to initial level, high treatment efficiency is considered to take place. Acid alpha-1 glycoprotein content reduction being 1.4-1.75 times as high, and nitrogen oxide being 1.4-1.75 times as high, when compared to initial level, low psoriatic erythrodermia treatment efficiency is considered to take place.;EFFECT: high accuracy of prognosis.